• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:杜宏金,余晓谭,李翰旭,万洛婷,邹瑜.新冠病毒SARS-CoV-2主蛋白酶3CLpro抑制剂的多步虚拟筛选[J].药学研究,2023,42(10):801-806[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2490次   下载 2965次 本文二维码信息
码上扫一扫!
新冠病毒SARS-CoV-2主蛋白酶3CLpro抑制剂的多步虚拟筛选
杜宏金1,余晓谭2,3,李翰旭2,万洛婷2,邹瑜2
字体:加大+|默认|缩小-
(1.国家药品监督管理局药品审评中心,北京 100038;2.武汉科技大学医学院药学系,湖北省职业病预防与控制重点实验室,湖北 武汉 430070;3.华中科技大学同济医学院药学院,湖北 武汉 430030)
摘要:
目的 通过构建多步虚拟筛选模型和方法,寻找有效筛选新冠状病毒SARS-CoV-2主蛋白酶3CLpro抑制剂的方法,为抗击COVID-19提供去潜在的候选药物。方法 利用Discovery Studio Client 2016和AutoDock Vina 1.5.6软件对ZINC 数据库共5811个化合物进行基于结构的虚拟筛选,然后基于配体的药效团模型,选取最佳模型后进行基于配体的虚拟筛选,最后基于构效关系筛选出与抗病毒有关的药物。结果 经过3步筛选最终得到11个具有高亲和力、高拟合值和适当药理作用的化合物。结论 通过3种不同方法的多步筛选可以快速寻找出具有高活性的候选化合物,表明构建的虚拟筛选的方法和模型有效,为今后抗COVID-19药物研究提供了潜在的研究工具。
关键词:  COVID-19  SARS-CoV-2  虚拟筛选  药物再利用  分子对接
DOI:10.13506/j.cnki.jpr.2023.10.010
基金项目:国家自然科学基金资助项目(No.82003593);湖北省自然科学基金资助项目(No.2019CFB104)
Multi-step virtual screening for searching the 3Clpro inhibitor of the main protease of the new coronavirus SRAS-CoV-2
DU Hongjin1,YU Xiaotan2,3,LI Hanxu2,WAN Luoting2,ZOU Yu2
(1.Center for Drug Evaluation, National Medical Products Administration, Beijing 100038,China;2.Hubei Provincial Key Laboratory of Occupational Disease Prevention and Control, Department of Pharmacy, Wuhan University of Science and Technology, Wuhan 430065,China;3 School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030,China)
Abstract:
Objective To construct a multi-step virtual screening model and method to find an effective method for screening the 3Clpro inhibitor of the main protease of the new coronavirus SARS-CoV-2, so as to provide potential candidate drugs for COVID-19 drug research.Methods Discovery Studio Client 2016 and Autodock vina 1.5.6 software were used to conduct structural-based virtual screening of 5811 compounds from the ZINC database, and the ligand-based pharmacophore model was constructed. After selecting the best model, the ligand-based virtual screening was performed. Finally, the antiviral drugs were screened based on pharmacological effects.Results After three steps of screening, 11 compounds with high affinity, high fitting value and appropriate pharmacological effects were finally obtained.Conclusion After three different screening, the candidate compounds with high activity can be quickly found, indicating that the virtual screening method and model are effective, which will greatly reduce the range of drug screening against COVID-19 and provide potential research tools for future COVID-19 drug discovery.
Key words:  COVID-19  SARS-CoV-2  Virtual screening  Drug repurposing  Molecule docking
今日访问量:2470    总访问量:55338900
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司